Case Report: Co‐Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia—Diagnostic and Perioperative Management Challenges
Cancer Reports · 2026-03 · 9 (3)
DOI: 10.1002/cnr2.70512 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Reports, online erschienen am 06.03.2026. Verfasst von He Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Suining First People's Hospital, Suining, Sichuan, China. Hauptthemen laut MEDLINE: Afibrinogenemia, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suining Health Science and Technology Project.
Abstract (Originalsprache)
Background
Congenital dysfibrinogenemia (CD), a rare autosomal dominant coagulation disorder, poses significant perioperative challenges in oncologic surgery due to hypofibrinogenemia and variable bleeding‐thrombosis risks. Case A 67‐year‐old woman presented with a 2.9 × 1.4 cm spiculated mass in the right middle lobe (RML) and persistent hypofibrinogenemia (0.56–0.58 g/L). Despite conventional fresh frozen plasma and cryoprecipitate transfusions, fibrinogen levels remained critically low. Preoperative optimization with human fibrinogen concentrates (total 4.0 g) normalized levels to 1.76 g/L within 24 h, enabling video‐assisted thoracoscopic (VATS) RML lobectomy with systematic lymphadenectomy (pT1cN0M0, Stage IA3). Postoperatively, fibrinogen gradually declined to 0.68 g/L at 1‐month follow‐up, necessitating extended surveillance. Genetic testing identified a heterozygous FGA c.103C>T (Arg35Cys) mutation, confirming CD diagnosis and thrombotic risk.
Conclusion
This case establishes three paradigms: (1) Mandatory comprehensive coagulation profiling in pulmonary resection candidates to identify CD; (2) superiority of fibrinogen concentrate over plasma‐derived products for rapid, sustained hemostasis in CD; (3) individualized thromboprophylaxis balancing hemorrhagic‐thrombotic risks through genetic risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Suining First People's Hospital, Suining, Sichuan, China.
- Oncology, Suining First People's Hospital, Suining, Sichuan, China.
- Department of Oral and Maxillofacial Surgery, Suining First People's Hospital, Suining, Sichuan, China.
ORCID-Profile: He Zheng, Qingsong Wang, Mingpu Wang, Shu Luo, Yuzhen Ma, Zhengqiang Wan
Förderung
- Suining Health Science and Technology Project
Zitieren
APA
Zheng, H., Wang, Q., Wang, M., Luo, S., Ma, Y., & Wan, Z. (2026). Case Report: Co‐Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia—Diagnostic and Perioperative Management Challenges. Cancer Reports, 9(3). https://doi.org/10.1002/cnr2.70512
Vancouver
Zheng H, Wang Q, Wang M, Luo S, Ma Y, Wan Z. Case Report: Co‐Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia—Diagnostic and Perioperative Management Challenges. Cancer Reports. 2026;9(3). doi:10.1002/cnr2.70512
BibTeX
@article{Zheng2026,
author = {Zheng, He and Wang, Qingsong and Wang, Mingpu and Luo, Shu and Ma, Yuzhen and Wan, Zhengqiang},
title = {Case Report: Co‐Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia—Diagnostic and Perioperative Management Challenges},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {3},
doi = {10.1002/cnr2.70512}
}
EUVIMED